Group One Trading’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.44K Buy
1,000
+800
+400% +$1.6K ﹤0.01% 6990
2025
Q4
$274 Hold
200
﹤0.01% 7860
2025
Q3
$248 Sell
200
-26,400
-99% -$31.5K ﹤0.01% 8203
2025
Q2
$30.1K Buy
26,600
+20,900
+367% +$27.8K ﹤0.01% 5981
2025
Q1
$8.32K Buy
5,700
+5,500
+2,750% +$10.4K ﹤0.01% 6381
2024
Q4
$426 Sell
200
-100
-33% -$247 ﹤0.01% 7015
2024
Q3
$840 Sell
300
-16,500
-98% -$44K ﹤0.01% 6317
2024
Q2
$39.1K Buy
16,800
+5,100
+44% +$15K ﹤0.01% 4711
2024
Q1
$52.3K Sell
11,700
-72,700
-86% -$303K ﹤0.01% 4678
2023
Q4
$271K Sell
84,400
-5,200
-6% -$14.7K ﹤0.01% 3585
2023
Q3
$284K Buy
89,600
+23,800
+36% +$104K ﹤0.01% 3485
2023
Q2
$327K Buy
65,800
+25,800
+65% +$140K ﹤0.01% 3455
2023
Q1
$198K Buy
40,000
+39,600
+9,900% +$254K ﹤0.01% 3692
2022
Q4
$2.52K Sell
400
-3,200
-89% -$29.6K ﹤0.01% 6578
2022
Q3
$39K Buy
3,600
+3,100
+620% +$42.1K ﹤0.01% 5585
2022
Q2
$6K Sell
500
-800
-62% -$7.1K ﹤0.01% 6978
2022
Q1
$12K Sell
1,300
-49,600
-97% -$517K ﹤0.01% 7076
2021
Q4
$759K Buy
50,900
+50,800
+50,800% +$896K ﹤0.01% 3638
2021
Q3
$3K Sell
100
-2,500
-96% -$59.4K ﹤0.01% 7847
2021
Q2
$68K Buy
2,600
+2,400
+1,200% +$68.4K ﹤0.01% 6314
2021
Q1
$7K Sell
200
-300
-60% -$10.1K ﹤0.01% 7143
2020
Q4
$13K Sell
500
-100
-17% -$3.26K ﹤0.01% 5687
2020
Q3
$23K Sell
600
-1,200
-67% -$45.2K ﹤0.01% 5057
2020
Q2
$77K Buy
+1,800
New +$65.1K ﹤0.01% 4096
2020
Q1
Sell
-8,100
Closed -$210K 5188
2019
Q4
$210K Buy
8,100
+7,900
+3,950% +$218K ﹤0.01% 3134
2019
Q3
$5K Sell
200
-800
-80% -$22.8K ﹤0.01% 4753
2019
Q2
$27K Buy
1,000
+900
+900% +$25.1K ﹤0.01% 4052
2019
Q1
$3K Buy
+100
New +$2.9K ﹤0.01% 4509

Other funds holding ALLO